Institution: British Patient Capital
Headquarters: Sheffield, UK
AUM: £5.8 billion
Fund II, which closed November 30, 2021 and raised €650 million, will invest in the TMT sectors in the Western Europe region.
As shown below, British Patient Capital tends to focus its private equity fund commitments on venture and growth-equity vehicles worldwide.